NCT06292754

Brief Summary

Rotator cuff tears are one of the most common conditions encountered in orthopaedic practice leading to significant shoulder pain and functional deficit. The incidence of rotator cuff tears increases with age and previous trauma. Arthroscopic rotator cuff repair (ARCR) is a surgical procedure to reattach the torn edge of the tendon to the underlying bone, which can improve the clinical symptoms of patients. However, the retear rate after arthroscopic repair is as high as 94% (1). The high re-tear rate following cuff repair is due to the lack of a strong tendon to bone integration. The natural healing responses after surgical reattachment are too weak to regenerate strong tendon insertion, primarily owing to insufficient osteogenesis. To enhance the bone-tendon interface (BTI) healing, the investigators have developed a magnesium pin that can be applied to the cuff repair site to improve the BTI healing.This study is a single-center, randomized controlled trial to investigate the effect of using magnesium pin as a suture to augment rotator cuff repair. The intervention groups receives treated using magnesium pin additional to the suture anchor used routinely in clinical practice, whereas the control group receives routine suture anchor for the treatment-as-usual (TAU). The investigators hypothesize the magnesium pin applied in arthroscopic rotator cuff tears can promote BTI healing and reduce the cumulative retear rate with better functional outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
May 2024Dec 2026

First Submitted

Initial submission to the registry

February 5, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

March 5, 2024

Status Verified

February 1, 2024

Enrollment Period

2 years

First QC Date

February 5, 2024

Last Update Submit

February 27, 2024

Conditions

Keywords

ARCRMagnesium pin

Outcome Measures

Primary Outcomes (4)

  • Imaging Examinations

    Upper extremity Magnetic resonance imaging (MRI) for study participants will be collected at Baseline, at 3, 6 and 12 months. The Baseline (pre-operative) MRI follows standard of care imaging and will not follow the study MRI Image Acquisition Protocol. The Baseline MRI must occur within 6 months of enrollment into this study. MRI at 3, 6- and 12-months post-surgery will be collected per Image Acquisition Protocol. Total tendon thickness (mm), tendon length (mm), size of retear (anteroposterior /mediolateral), and shape of retear will be recorded.

    Baseline, post-operative 3 months, 6 months, and 12 months.

  • Cofield classification

    The Cofield classification system will be used for all MRI analyses to assess the size of full-thickness tears(FTT) : • Small = \< 1 cm • Medium = 1-3 cm • Large = 3-5 cm • Massive = \> 5 cm

    Baseline, post-operative 3 months, 6 months, and 12 months.

  • Sugaya Score

    The Sugaya score will be used to determine postoperative cuff integrity through magnetic resonance imaging classified into 5 categories: Type I to Type V. Type I indicates sufficient thickness with homogenously low intensity. Type II indicates sufficient thickness with partial high intensity. Type III indicates insufficient thickness without discontinuity. Type IV indicates presence of a minor discontinuity, suggesting a small full-thickness tear. Type V indicates the presence of a major discontinuity, suggesting a medium or large full-thickness tear.

    Baseline, post-operative 3 months, 6 months, and 12 months.

  • Goutallier Classification

    The Goutallier classification will be used to classify the fatty infiltration of the rotator cuff. The Goutallier classification ranges from a grade of 0 indicating a completely normal muscles without any fatty streaks to a grade of 4 which indicates that more fat than muscle is present . Grade 0: Completely normal muscle, without any fatty streaks, Grade 1: Some fatty streaks, Grade 2: Increased fatty infiltration, but more muscle than fat, Grade 3: Equal amounts of fat and muscle, Grade 4: more fat than muscle.

    Baseline, post-operative 3 months, 6 months, and 12 months.

Secondary Outcomes (20)

  • Height measurement

    baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months.

  • Weight measurement

    baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months.

  • BMI measurement

    baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months.

  • Shoulder flexibility (range of motion)

    baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months.

  • Shoulder muscle strength

    baseline, post-operative 2 weeks, 3 months, 6 months, and 12 months.

  • +15 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention groups receives treated using magnesium pin in additional to the suture anchor used routinely in clinical practice.

Procedure: magnesium pin in additional to the suture anchor

Control group

ACTIVE COMPARATOR

The control group receives routine suture anchor for the treatment-as-usual (TAU).

Procedure: routine suture anchor

Interventions

magnesium pin in additional to the suture anchor used routinely in clinical practice

Intervention group

routine suture anchor for the treatment-as-usual

Control group

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject requires Arthroscopic rotator cuff repair (ARCR) and amenable to repair.
  • Subject is \> 40 years of age (no upper limit);
  • Subject provides written informed consent for study participation using an Independent Ethical Committee (IEC) / Institutional Review Board (IRB) approved consent form;
  • Subject is willing and able to participate in required follow-up visits and is able to complete study activities.

You may not qualify if:

  • Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications;
  • Subjects with Samilson-Prieto osteoarthritis \> 2;
  • Subjects with current or prior infection of the ipsilateral shoulder;
  • Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, or chronic joint disease;
  • Subjects with prior shoulder surgery (not including rotator cuff repair (revision repair subject group only), biceps tenodesis/tenotomy, distal clavicle excision (DCE), ubacromial decompression);
  • Subjects with an irreparable or partially reparable rotator cuff tear;
  • Subjects with a subscapularis tear requiring repair;
  • Subjects requiring a concomitant labral fixation procedure;
  • Subjects requiring a concomitant os acromiale fixation procedure
  • Subjects with glenohumeral joint instability (multiple dislocations/subluxations);
  • Subjects with a subacromial or intra-articular injection within 3 months prior to surgery;
  • Subjects with condition(s) that contraindicate or complicate outcomes of ARCR e.g., \> Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy \> Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head or glenoid, history of immunodeficiency disorders, history of chronic inflammatory disorders, oral or injected steroid use in last 4 weeks;
  • Pregnancy or possibility of pregnancy
  • Patient's inability to understand written and spoken Chinese, Mandarin or English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Location

Central Study Contacts

Michael Tim-Yun ONG

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

February 5, 2024

First Posted

March 5, 2024

Study Start

May 1, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 5, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
starting 6 months after publication
Access Criteria
Journal reviewers

Locations